HydraScalp with Keravive study highlights improvements in scalp hydration and overall scalp quality following a single treatment
Hydrafacial study shows improvements in skin hydration and overall skin quality following a series of Hydrafacial treatments across all Fitzpatrick skin types I-VI
LONG BEACH, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems (NASDAQ: SKIN), home to flagship brand Hydrafacial™, today announced that findings from two new clinical studies evaluating HydraScalp™ with Keravive™ and Hydrafacial™ treatments will be presented at the Science of Skin Summit, September 17-20, 2026, in Austin, Texas.
The research evaluates the effects of a single HydraScalp treatment on key measures of the scalp microenvironment, as well as changes in skin hydration and overall skin quality following a series of monthly Hydrafacial treatments across Fitzpatrick skin types I-VI.
“SkinHealth Systems is committed to delivering clinically validated solutions that providers can confidently integrate into their practices,” said Whitney Cypes, Chief Brand and Clinical Innovation Officer of SkinHealth Systems. “The new clinical data reinforce the efficacy of Hydrafacial and HydraScalp treatments across a broad range of skin and scalp concerns, helping providers deliver meaningful benefits to nearly every client they serve.”
Clinical Evaluation of a Single HydraScalp Treatment on the Scalp Microenvironment
A randomized, evaluator-blinded clinical study evaluated the effects of a single HydraScalp treatment on hydration, desquamation, epidermal barrier integrity and overall scalp quality, key measures associated with a healthy scalp microenvironment.
Key Findings:
Poster Title: Optimization of the Scalp Microenvironment Following a Single HydraScalp™ Treatment: Results From a Randomized, Evaluator-Blinded Clinical Study
Author: Menas Kizoulis, Global Medical Affairs, SkinHealth Systems
Clinical Evaluation of the Benefits of Monthly Hydrafacial Treatments Across All Fitzpatrick Skin Types
This Phase IV open-label study evaluated changes in skin hydration and overall skin quality following a series of monthly Deluxe Hydrafacial treatments with the Hydrafacial ReGen GF™ Booster among participants with Fitzpatrick skin types I-VI.
Key Findings:
Poster Title: Clinical Improvements in Skin Hydration and Overall Skin Quality Following Serial Hydrafacial® Treatments Across Fitzpatrick Skin Types I–VI: Results From a Phase IV Open-Label Study
Authors: Ted Lain, MD, MBA, of the Austin Institute for Clinical Research, and Menas Kizoulis, Global Medical Affairs, SkinHealth Systems
E-Posters will be displayed digitally throughout the summit on multiple touchscreen monitors and accessible in the Science of Skin Summit mobile app.
About SkinHealth Systems
SkinHealth Systems (NASDAQ: SKIN) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers. Anchored by Hydrafacial™, a leading and widely requested professional skincare treatment, and supported by complementary offerings including SkinStylus™ microneedling and HydraScalp™ with Keravive™, SkinHealth Systems combines advanced device technology, proprietary consumables, and clinical validation to deliver trusted treatment experiences through an omnichannel network of providers worldwide. Learn more at skinhealthsystems.com or follow us on LinkedIn. Local providers can be found at hydrafacial.com/find-a-hydrafacialist.
Contacts:
Press: press@skinhealthsystems.com
Investors: IR@skinhealthsystems.com
Source: SkinHealth Systems